Affordable Access

A tumor suppressive DNA translocase named FANCM.

Authors
  • Basbous, Jihane
  • Constantinou, Angelos
Publication Date
Feb 04, 2019
Source
HAL-INRIA
Keywords
Language
English
License
Unknown
External links

Abstract

FANCM is named after Fanconi anemia (FA) complement group M. The clinical symptoms of FA include congenital abnormalities, pancytopenia, and cancer proneness. However, recent studies reveal that biallelic inactivation of FANCM does not cause the constellation of FA symptoms, but predisposes patients to cancer and infertility. FANCM is a tumor suppressor gene that encodes a conserved and structure-specific DNA translocase. It controls the outcome of homologous recombination and facilitates DNA replication across a variety of natural and chemically induced obstacles. This review details our current understanding of FANCM as a facilitator of the cellular functions of caretaker proteins, including FA, Bloom syndrome, and Ataxia telangiectasia and RAD3-related proteins, which collectively ensure the maintenance of chromosome stability during DNA replication.

Report this publication

Statistics

Seen <100 times